Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NT-proBNP and hs-CRP may be useful biomarkers for identifying and stratifying repaired TOF patients at increased risk of RV systolic dysfunction.

Journal of family medicine and primary care·2026
Same author

Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality.

ESC heart failure·2026
Same author

Lumen-Stent Mismatch Affects Long-Term Strut Healing After Primary PCI of Left Main Lesions: An Exploratory Follow-Up OCT Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Time for a new category: "acute-on-chronic" hypertensive target organ damage.

Expert review of cardiovascular therapy·2026
Same author

Prognostic value of multi-marker stress echocardiography.

Future cardiology·2026
Same author

Ecological Correlates of Differences in Mean Age at Death Across Nearly Extinct Cohorts: The Role of Dietary Habits.

Nutrients·2026

Related Experiment Video

Updated: Jun 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stenting a myocardial bridge: a wrong decision in STEMI?

Miloje Tomasevic1, Miodrag Dikic, Miodrag Ostojic

  • 1Division of Cardiology, Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia. mmntom@eunet.rs

Acta Cardiologica
|March 31, 2011
PubMed
Summary

Stenting myocardial bridges (MB) in STEMI patients risks coronary rupture. A case report details a coronary fistula after MB stenting, successfully treated with stent graft implantation for improved outcomes.

Related Experiment Videos

Last Updated: Jun 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Myocardial bridges (MB) with significant systolic compression in the mid left anterior descending artery (LAD) present challenges for stent implantation in ST-elevation myocardial infarction (STEMI) settings.
  • Coronary rupture risk during stenting is elevated due to thin arterial intima, thin myocardial layers, smaller LAD diameter at the MB, and high balloon inflation pressures.

Observation:

  • A case of a coronary fistula between the mid LAD and the right ventricle occurred after MB stenting in a STEMI patient.
  • The patient experienced spontaneous angiographic deterioration several days post-procedure.

Findings:

  • Coronary fistula formation is a potential complication following stent implantation in myocardial bridges.
  • Stent graft implantation demonstrated effectiveness in managing a coronary fistula with increasing flow.

Implications:

  • This case highlights the importance of considering coronary fistula as a complication of MB stenting.
  • Stent graft intervention offers a viable therapeutic strategy for managing post-procedural coronary fistulas, especially those with hemodynamic significance.